ADSlay

5.4K posts

ADSlay banner
ADSlay

ADSlay

@slay_ad

Quince Therapeutics $QNCX, DD account. Disclaimer: No financial advise to buy or sell any stocks. Not affiliated. I have a long position.

Katılım Aralık 2020
1 Takip Edilen220 Takipçiler
ADSlay retweetledi
Quince Therapeutics
Quince Therapeutics@Quince_Tx·
$QNCX Investors: We are pleased to participate at the British Paediatric Neurology Association 2026 Annual Meeting with a poster presentation highlighting previously published safety data from the long-term treatment of children with A-T. Learn more here: ir.quincetx.com/news-releases/…
Quince Therapeutics tweet media
English
2
1
3
2.1K
ADSlay retweetledi
Antonio Costa
Antonio Costa@ACInvestorBlog·
$QNCX Quince Therapeutics Presents Safety Data from Long-Term eDSP Treatment in Children with Ataxia-Telangiectasia at British Paediatric Neurology Association Annual Meeting
English
1
1
4
4.2K
ADSlay retweetledi
Wolf
Wolf@DeltaGammaThet2·
What’s interesting about the $QNCX story is that we already know the drug works. Steroids, in this case dexamethasone, is a tried therapy for AT. So this isn’t a, “Will it or won’t it?” story of biotech, per sè. We already know it does. The real question is that of repeatability.
English
2
1
1
599
ADSlay retweetledi
Wolf
Wolf@DeltaGammaThet2·
Some more bullish $QNCX tidbits. Take a look of who's been adding in the past few months in anticipation of Phase 3. Some very sharp managers, including Millennium and anchor investor, Nantahala. Prominent biotech multi-baggers in the past for both these managers.
English
1
1
1
493
ADSlay retweetledi
Bull Stock Picks
Bull Stock Picks@Bullstkpicks·
One month to go and I expect very positive results. Remember this opens up many other diseases that this platform will be able to go after. This is as much about a platform as it is this one disease. That isn’t priced into the stock at all. Positive data on this disease pushes this over $20, then other indications started getting priced in as potential and that pushes us much much higher
English
1
2
1
871
ADSlay retweetledi
Braden TeWinkel
Braden TeWinkel@braden_tewinkel·
$qncx multiple $300k buys today leading to all this green. Whales are loading the boat!!
English
1
1
5
892
ADSlay retweetledi
Omni
Omni@Omnitrader69·
Today feels like yesterday, SPY green while a bunch of my stuff is tanking for whatever reason. $OCUL standout strength though. $QNCX some buyers again also.
English
0
1
1
780
ADSlay retweetledi
Wolf
Wolf@DeltaGammaThet2·
CEO Dirk Thye recently received 1 million in options (4 year vest, strike of $3.08 - ATM). Board members have opted to receive retainers and compensation in all options, a break from the past where it was a mix of options + cash. Incentives are aligned here.
English
0
1
2
619
ADSlay retweetledi
Wolf
Wolf@DeltaGammaThet2·
.. we get a powerful result. I can see why management is so bullish. It would be hard to argue why a clinician would not be willing to offer a therapy with nearly 3x the potency for a young family devastated by the diagnosis of AT.
English
2
1
0
234
ADSlay retweetledi
Wolf
Wolf@DeltaGammaThet2·
If QNCX can repeat the results from the 6-9 age group, this should translate to an approximate 2.5-3.0x MORE POWERFUL treatment than IntraBio's recent results. Translating (and it is an approximation) IntraBio's SARA score and the ATTeST mICARS score to the RmICARS...
English
1
1
0
216
ADSlay retweetledi
Lovejoy
Lovejoy@LovejoyVapor·
@VIPSheffTrades I like how enthusiastic you are, but boy would I like to see some insider buying at $QNCX!
English
1
1
0
246
ADSlay retweetledi
Wolf
Wolf@DeltaGammaThet2·
Bullish $QNCX. Some perceive IntraBio's recent phase 3 as a threat to QNCX's upcoming top-line results. I would argue that knowing IntraBio's results, the forthcoming QNCX top-line has been de-risked.
English
2
2
4
1.4K
ADSlay
ADSlay@slay_ad·
@fcminaker Agreed and Dirk said so in above clip — "ten years ago". But good example of a biotech's journey with a happy ending that touches $QNCX so what if even remotely
English
0
0
1
619
fcminaker
fcminaker@fcminaker·
@slay_ad Don't think they had much influence on that outcome given they both left in 2016 when $CDTX was focused on antifungals.
English
1
0
0
70

Keşfet

@VIPSheffTrades @fcminaker @elonmusk @BarackObama @taylorswift13 @cristiano @BillGates @NASA